» Articles » PMID: 32500102

ESHRE PGT Consortium Good Practice Recommendations for the Detection of Structural and Numerical Chromosomal Aberrations

Overview
Journal Hum Reprod Open
Date 2020 Jun 6
PMID 32500102
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The field of preimplantation genetic testing (PGT) is evolving fast, and best practice advice is essential for regulation and standardisation of diagnostic testing. The previous ESHRE guidelines on best practice for PGD, published in 2005 and 2011, are considered outdated, and the development of new papers outlining recommendations for good practice in PGT was necessary. The current paper provides recommendations on the technical aspects of PGT for chromosomal structural rearrangements (PGT-SR) and PGT for aneuploidies (PGT-A) and covers recommendations on array-based comparative genomic hybridisation (aCGH) and next-generation sequencing (NGS) for PGT-SR and PGT-A and on fluorescence in situ hybridisation (FISH) and single nucleotide polymorphism (SNP) array for PGT-SR, including laboratory issues, work practice controls, pre-examination validation, preclinical work-up, risk assessment and limitations. Furthermore, some general recommendations on PGT-SR/PGT-A are formulated around training and general risk assessment, and the examination and post-examination process. This paper is one of a series of four papers on good practice recommendations on PGT. The other papers cover the organisation of a PGT centre, embryo biopsy and tubing and the technical aspects of PGT for monogenic/single-gene defects (PGT-M). Together, these papers should assist everyone interested in PGT in developing the best laboratory and clinical practice possible.

Citing Articles

Preimplantation genetic testing for aneuploidy on previously cryopreserved unbiopsied blastocysts: a cohort study in women with IVF pregnancy loss.

Cai H, Kirshenbaum M, Zhang D, Bai H, Li W, Xue X Reprod Biol Endocrinol. 2025; 23(1):31.

PMID: 40025495 PMC: 11874781. DOI: 10.1186/s12958-025-01371-6.


ChromInst: a multicentre evaluation of robustness in aneuploidy and structural rearrangement testing.

Niu W, Dai S, Hu L, He Y, Zhang X, Xue X J Transl Med. 2025; 23(1):230.

PMID: 40011874 PMC: 11863937. DOI: 10.1186/s12967-025-06242-7.


Noninvasive preimplantation genetic testing for aneuploidy using blastocyst spent culture medium may serve as a backup of trophectoderm biopsy in conventional preimplantation genetic testing.

Chen S, Wang L, Hu Y, Yao Y, Gao F, Chang C BMC Med Genomics. 2025; 18(1):34.

PMID: 39984972 PMC: 11846158. DOI: 10.1186/s12920-025-02106-7.


Reproductive outcomes after preimplantation genetic testing in couples with sex chromosome abnormalities: a retrospective cohort study of 83 couples.

Yang T, Xiao M, Sun X, Li H J Assist Reprod Genet. 2024; 41(12):3415-3421.

PMID: 39476305 PMC: 11707093. DOI: 10.1007/s10815-024-03303-6.


Preimplantation Genetic Testing for Aneuploidy (PGT-A) in In-Vitro Fertilisation (IVF) Treatment: Study Protocol for Pilot Phase of a Randomised Controlled Trial.

Beebeejaun Y, Nicolaides K, Mania A, Sarris I, Sunkara S J Clin Med. 2024; 13(20).

PMID: 39458142 PMC: 11508202. DOI: 10.3390/jcm13206192.


References
1.
Harton G, De Rycke M, Fiorentino F, Moutou C, Sengupta S, Traeger-Synodinos J . ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod. 2010; 26(1):33-40. DOI: 10.1093/humrep/deq231. View

2.
Magli M, Montag M, Koster M, Muzi L, Geraedts J, Collins J . Polar body array CGH for prediction of the status of the corresponding oocyte. Part II: technical aspects. Hum Reprod. 2011; 26(11):3181-5. PMC: 3196879. DOI: 10.1093/humrep/der295. View

3.
. Guidelines for good practice in PGD: programme requirements and laboratory quality assurance. Reprod Biomed Online. 2008; 16(1):134-47. DOI: 10.1016/s1472-6483(10)60567-6. View

4.
Kotzot D . Prenatal testing for uniparental disomy: indications and clinical relevance. Ultrasound Obstet Gynecol. 2007; 31(1):100-5. DOI: 10.1002/uog.5133. View

5.
Geraedts J, Montag M, Magli M, Repping S, Handyside A, Staessen C . Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results. Hum Reprod. 2011; 26(11):3173-80. PMC: 3196878. DOI: 10.1093/humrep/der294. View